Lexeo Therapeutics (LXEO) Revenue: 2022-2024
Historic Revenue for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to -$137,000.
- Lexeo Therapeutics' Revenue rose 7.41% to -$50,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$205,000, marking a year-over-year change of. This contributed to the annual value of -$137,000 for FY2024, which is 33.17% up from last year.
- Lexeo Therapeutics' Revenue amounted to -$137,000 in FY2024, which was up 33.17% from -$205,000 recorded in FY2023.
- Lexeo Therapeutics' Revenue's 5-year high stood at $654,000 during FY2022, with a 5-year trough of -$205,000 in FY2023.
- Moreover, its 3-year median value for Revenue was -$137,000 (2024), whereas its average is $104,000.
- As far as peak fluctuations go, Lexeo Therapeutics' Revenue slumped by 131.35% in 2023, and later soared by 33.17% in 2024.
- Lexeo Therapeutics' Revenue (Yearly) stood at $654,000 in 2022, then crashed by 131.35% to -$205,000 in 2023, then skyrocketed by 33.17% to -$137,000 in 2024.